UB Paderborn / Katalog / Suche / in CDI

Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

Journal of internal medicine, 2015-06, Vol.277 (6), p.717-726

2015

Volltextzugriff (PDF)

Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement

Journal of internal medicine, 2021-04, Vol.289 (4), p.523-531

2021

Volltextzugriff (PDF)

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2019-01, Vol.9 (1), p.167, Article 167

2019

Volltextzugriff (PDF)

Gut microbiota diversity predicts immune status in HIV-1 infection

AIDS (London), 2015-11, Vol.29 (18), p.2409-2418

2015

Volltextzugriff (PDF)

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Mucosal immunology, 2016-11, Vol.9 (6), p.1455-1465

2016

Volltextzugriff (PDF)

Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation

Journal of hepatology, 2023-10, Vol.79 (4), p.955-966

2023

Volltextzugriff (PDF)

Markers of microbial translocation predict hypertension in HIV‐infected individuals

HIV medicine, 2013-07, Vol.14 (6), p.354-361

2013

Volltextzugriff (PDF)

Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection

eLife, 2023-02, Vol.12

2023

Volltextzugriff (PDF)

Association of the Kynurenine Pathway of Tryptophan Metabolism With Human Immunodeficiency Virus-Related Gut Microbiota Alterations and Visceral Adipose Tissue Accumulation

The Journal of infectious diseases, 2022-06, Vol.225 (11), p.1948-1954

2022

Volltextzugriff (PDF)

The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages

AIDS (London), 2018-07, Vol.32 (12), p.1589-1598

2018

Volltextzugriff (PDF)

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Scientific reports, 2024-02, Vol.14 (1), p.3704-3704, Article 3704

2024

Volltextzugriff (PDF)

Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART

Journal of acquired immune deficiency syndromes (1999), 2015-12, Vol.70 (4), p.329

2015

Volltextzugriff (PDF)

Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals

AIDS (London), 2019-03, Vol.33 (4), p.645-653

2019

Volltextzugriff (PDF)

Cardiac function is normal in most patients recovered from COVID-19

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings

Journal of antimicrobial chemotherapy, 2009-12, Vol.64 (6), p.1126-1129

2009

Volltextzugriff (PDF)

Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitis

Scandinavian journal of gastroenterology, 2021-04, Vol.56 (4), p.443-452

2021

Volltextzugriff (PDF)

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy

AIDS (London), 2010-07, Vol.24 (11), p.1733-1737

2010

Volltextzugriff (PDF)

G.P.19.05 Statin associated myopathy with normal creatine kinase levels: Case report from a Norwegian family

Neuromuscular disorders : NMD, 2007, Vol.17 (9), p.895-895

2007

Volltextzugriff (PDF)

Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome

European heart journal, 2004-02, Vol.25 (4), p.349-355

2004

Volltextzugriff (PDF)

Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study

BMC infectious diseases, 2016-04, Vol.16 (170), p.176-176, Article 176

2016

Volltextzugriff (PDF)

Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood

Innate immunity (London, England), 2014-07, Vol.20 (5), p.552-560

2014

Volltextzugriff (PDF)

High Levels of HMGB1 in Plasma May Be due to Ex Vivo Cell Necrosis

Anticancer research, 2012-09, Vol.32 (9), p.4067-4069

2012

Volltextzugriff (PDF)

The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis

Journal of hepatology, 2017, Vol.66 (1), p.S554-S555

2017

Volltextzugriff (PDF)

Anticoagulant effects of an antidiabetic drug on monocytes in vitro

Thrombosis research, 2011-11, Vol.128 (5), p.e100-e106

2011

Volltextzugriff (PDF)

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis

Journal of hepatology, 2015-04, Vol.62, p.S793-S794

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Gut microbiota diversity predicts immune status in HIV-1 infection

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation

Markers of microbial translocation predict hypertension in HIV‐infected individuals

Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection

Association of the Kynurenine Pathway of Tryptophan Metabolism With Human Immunodeficiency Virus-Related Gut Microbiota Alterations and Visceral Adipose Tissue Accumulation

The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART

Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals

Cardiac function is normal in most patients recovered from COVID-19

Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings

Associations of neopterin and kynurenine-tryptophan ratio with survival in primary sclerosing cholangitis

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy

G.P.19.05 Statin associated myopathy with normal creatine kinase levels: Case report from a Norwegian family

Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome

Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study

Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood

High Levels of HMGB1 in Plasma May Be due to Ex Vivo Cell Necrosis

The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis

Anticoagulant effects of an antidiabetic drug on monocytes in vitro

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis

Suchergebnisse filtern